|
|
|
Vol. 13, No. 9, pp. 1073-1078, May 1, 1999
Department of Microbiology, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 1 Department of Microbiology, University of Virginia, Charlottesville, Virginia 22908 USA
| |
Abstract |
|---|
|
|
|---|
The c-Myb transcription factor is important for fetal hematopoiesis and has been proposed to mediate later stages of lymphocyte development. Using homozygous null c-Myb/Rag1 chimeric mice, we have determined that c-Myb plays an important role in the differentiation of macrophages and lymphocytes from precursor stem cells. We also determine that deletion of c-Myb leads to a complete block in early T cell development just before the oligopotent thymocyte matures into the definitive T cell precursor. These data indicate that c-Myb plays an important role at multiple stages of hematopoiesis and is required at an early stage of T cell development.
| |
Introduction |
|---|
|
|
|---|
The c-Myb transcription factor binds to cis-acting
transcriptional control elements of genes critical for early
hematopoiesis (Lipsick 1996
; Ness 1996
). Many of
these genes, such as c-kit and c-myc (Cogswell et al.
1993
; Ratajczak et al. 1998
) are important for hematopoietic stem cell
(HSC) proliferation and differentiation. These observations led to the
hypothesis that c-Myb induces the expression of genes necessary for HSC
lineage commitment. c-Myb may also have a critical role at later
committed stages of hematopoietic cell development. Consensus c-Myb
recognition sites have been identified in the promoters and enhancers
of genes important in the regulation of late stages of lineage
commitment (Lipsick 1996
; Ness 1996
). For example, c-Myb binding sites
have been found in the transcriptional control elements of genes
important in mediating T cell development and selection, indicating
that c-Myb may be important in mediating these processes (Siu et al.
1992
; Nakayama et al. 1993
; Hernandez-Munain and Krangel 1994
; Hsiang
et al. 1995
; M. Adlam, R.D. Allen, and G. Siu, in prep.).
T cells mature and acquire their antigenic specificity and self-major
histocompatibility complex (MHC) restriction during a complex selection
process in the thymus (Fowlkes and Pardoll 1989
; Robey and Fowlkes
1994
). The earliest committed T cell precursor that migrates to the
thymus does not express the CD4 and CD8 accessory molecules and the
T-cell antigen receptor (TCR), and is referred to as the
double-negative (DN) thymocyte. DN thymocyte stages can be
subfractionated into different developmental stages on the basis of
their expression of other cell-surface markers (Godfrey and Zlotnik
1993
; Godfrey et al. 1993
). The most immature DN thymocyte is
CD44loCD25
; although committed to the T cell lineage,
these initial thymic immigrants are oligopotent and retain the ability
to develop into T and B lymphocytes, NK cells, and dendritic cells
(Guidos et al. 1989a
,b
; Wu et al. 1991
; Shortman and Wu, 1996
). The
CD44loCD25
DN thymocyte subsequently commits to the T
cell lineage and matures into the CD44+CD25
population and
subsequently the CD44+CD25+ population, where it begins to
rearrange its TCR
-chain genes (Godfrey et al.
1993
). The rearrangement process continues while the thymocyte develops
into the CD44
CD25+ cell; upon expressing a functional TCR
chain, the cell down-regulates CD25 and up-regulates expression of the
CD4 and CD8 coreceptor molecules and the TCR. This latter stage,
referred to as the double-positive (DP) stage, is where the thymocyte
begins to undergo the repertoire selection process (Bevan et al. 1994
;
Nossal 1994
; Fink and Bevan 1995
). Surviving T cells will down-regulate
either CD8, to become the mature CD4 single-positive (SP) T cell, or
CD4, to become the mature CD8 SP T cell (Robey and Fowlkes 1994
). c-Myb
has been shown to induce the function of the promoter of the CD4 gene
(Siu et al. 1992
; Nakayama et al. 1993
) and is one of three factors that induce the function of the stage-specific CD4 silencer (Kim and
Siu 1998
; H.K. Kim and G. Siu, in prep.; M. Adlam, R.D. Allen, and G. Siu, in prep.). In addition, c-Myb has been shown to induce the
enhancers that mediate expression of the genes encoding the TCR
and
chains (Hernandez-Munain and Krangel 1994
; Hsiang et al.
1995
). All of these proteins are important at the later DP and SP
stages of thymopoiesis.
Studying the role of c-Myb at later stages of lymphopoiesis using
conventional targeted disruption techniques has been frustrated by the
early lethality of homozygous null c-Myb mice, which die before
definitive lymphopoiesis begins. Transgenic mice that overexpress a
dominant-negative form of Myb in T cells have small thymuses with an
expanded population of CD4
CD8+ thymocytes (Badiani et al. 1994
)
undergoing apoptosis (Taylor et al. 1996
). To study directly the role
of c-Myb in lymphocyte development, we generated and analyzed
homozygous null c-Myb/Rag1 chimeric
(Rag1
/
c-Myb
/
)
mice. We determine that c-Myb is important for the proper development of lymphocytes and macrophages, and is required at a specific stage
early in T cell development.
| |
Results |
|---|
|
|
|---|
Mature lymphocytes and macrophages do not develop from
c-Myb
/
precursor cells
As discussed above, previous experiments have demonstrated that
the homozygous disruption of the c-Myb gene results in death at days 13-15 of embryogenesis (Mucenski et al. 1991
). Therefore, it
was not possible to study the role of c-Myb in lymphopoiesis, as
development of mature fetal lymphocytes occurs only later in embryogenesis. To avoid this problem, we utilized the
Rag1
/
blastocyst chimera
system (Chen et al. 1993
). Because lymphocytes require functional
antigen receptor gene rearrangements to develop, mice deficient in the
recombination enzyme Rag1 cannot generate mature lymphocytes. In the
Rag1
/
blastocyst chimera
system, chimeric mice are generated by implanting c-Myb
/
ES cells into
blastocysts generated from
Rag1
/
mice. Resulting mice are
chimeric in all tissues except for the lymphoid system, where
lymphocytes that develop past the stage defined by antigen receptor
gene rearrangement derive solely from the implanted ES cells.
Eleven
Rag1
/
c-Myb
/
mice were generated. We have used PCR analyses of genomic DNA as well
as genomic blots to assay the chimerism in the brain, kidney, large
intestine, liver, heart, tail, thymus, small intestine, lung, and
skeletal muscle of these mice (data not shown). We can detect chimerism
in each of these tissues in a subset of
Rag1
/
c-Myb
/
mice, ranging from 2/11 for the brain to
7/11 for the liver and skeletal muscle; these data
indicate that the c-Myb
/
ES
cells are capable of contributing to the development of multiple somatic cell types.
Despite their ability to contribute to a wide variety of somatic
tissues, c-Myb
/
ES cells were
unable to repopulate most mature cells of the immune system. We cannot
detect mature splenic B220+mIgM+ B cells in the
Rag1
/
c-Myb
/
mice, nor can we detect mature splenic CD4 SP and CD8 SP T cells or CD4
SP, CD8 SP, and DP thymocytes (Fig. 1). Analysis of
macrophages in Rag1
/
blastocyst chimeras is difficult as their development does not depend
on functional Rag genes; thus, macrophages in the chimeric mice may originate from both the
c-Myb
/
and the
Rag1
/
lineages. To identify
c-Myb
/
ES cell-derived
macrophages, we took advantage of allelic differences in the Ly9
molecule between the c-Myb
/
cells and Rag1
/
cells.
Hematopoietic cells from the
Rag1
/
mice express the
Ly9.2 allele, whereas cells originating from the
c-Myb
/
cells express the
Ly9.1 allele (Ledbetter and Herzenberg 1979
). We can thus
identify precursor cells originating from
c-Myb
/
stem cells using an
antibody that distinguishes between the two Ly9 isoforms. Splenocytes
were harvested from
Rag1
/
c-Myb
/
,
Rag1
/
c-Myb+/
,
and Rag1
/
mice as well
as from +/+ 129 mice, which is the genetic
background of the ES cell used to generate the
c-Myb
/
cells (Mucenski et al.
1991
). As expected, macrophages are Ly9.1+ in the 129 mice and
Ly9.1
in the Rag1
/
mice
(Fig. 2). The Mac-1+Gr-1
population in the
Rag1
/
c-Myb+/
mice contain both Ly9.1+ and Ly9.1
cells, indicating that
Rag1
/
c-Myb+/
ES cells are capable
of repopulating the macrophage compartment. The macrophage population
in the
Rag1
/
c-Myb
/
mice are Ly9.1
, indicating that the macrophages in these mice are
derived solely from the Rag1
/
blastocyst cells, indicating that the deletion of the c-Myb
gene leads to defective macrophage development. Thus, we conclude that c-Myb plays an important role in the development of both the lymphoid and macrophage lineages.
|
|
Early thymocyte precursors develop from
c-Myb
/
stem cells
Although the lack of detectable mature and immature
lymphocytes in the
Rag1
/
c-Myb
/
mice
is consistent with an early pluripotent HSC defect, it is possible that
the defect occurs after the stem cell commits to the lymphocyte lineage
but before antigen receptor gene rearrangement. Because
Rag1
/
-derived lymphocyte
precursors can also develop to these stages, a block in development of
the c-Myb
/
stem cells would be
difficult to detect using flow cytometric analyses with the standard
lineage markers. To address this issue, we determined the extent of Ly9
allelism in early B and T cell precursors isolated from the chimeric
mice (Fig. 3; data not shown). We were unable to
detect immature Ly9.1+B220+CD43+ B cells in the bone marrow in
any of the
Rag1
/
c-Myb
/
mice (data not shown), indicating that, as for macrophages, the c-Myb
/
ES hematopoietic stem
cells cannot develop to the point of commitment to the B cell lineage.
To analyze the early thymic precursor cells, we utilized antibodies to
the CD44 and CD25 molecules. (Godfrey and Zlotnik 1993
; Godfrey et al.
1993
). Mice that have homozygous null mutations in their Rag
genes have a developmental block at the
CD44+/loCD25+ stages as the result of
their inability to generate a successful rearrangement of their
TCR genes[Godfrey et al. (1993)
; Fig. 3A]. Five of
eleven
Rag1
/
c-Myc
/
mice contained cells derived from
c-Myb
/
ES cells in the
CD44loCD25
DNA population. As can be seen in Figure 3, we
detect Ly9.1+CD44loCD25
DN thymocytes in the
Rag1
/
c-Myb
/
chimeric mice, indicating this expanded population represents a stage
that is blocked for further development (Fig. 3B). The presence of this
early thymocyte originating from the
c-Myb
/
ES cells and its
failure to develop further indicate that c-Myb plays an essential role
for the developmental progression of an early T cell precursor.
|
The CD44loCD25
DN thymocytes in the
Rag1
/
c-Myb
/
mice have germ-line TCR
-chain genes
The expanded Ly9.1+CD44loCD25
thymocytes
observed in the
Rag1
/
c-Myb
/
mice may represent thymocyte precursors of two different developmental stages: the recent oligopotent immigrant from the bone marrow; or the
late DN precursor to the DP thymocyte. Flow cytometry data using
different early thymocyte markers indicate that the phenotype of this
population is consistent with that of the early DN thymocyte (Fig. 3;
data not shown); the lack of Ly9.1+CD44+CD25+ thymocytes in
the
Rag1
/
c-Myb
/
mice also supports the hypothesis that thymopoiesis is blocked previous
to this step (Fig. 3B). However, it is still possible that this
population represents the late DN thymocyte population that has
modified marker expression due to the deletion of the c-Myb
gene. To confirm that this population is the earliest thymic precursor,
we analyzed thymocytes from the
Rag1
/
c-Myb
/
mice for rearrangement of the TCR
-chain gene (Fig.
4). As discussed above, the earliest
CD44lo/+CD25
DN thymocyte has not begun
rearranging the TCR genes, whereas cells of all subsequent T cell
developmental stages have at least partial
D
-J
rearrangements. Thus, should the
expanded CD44loCD25
DN population detected in the
Rag1
/
c-Myb
/
mice represent the earliest DN precursor, we predict that we would only
detect the germ-line configuration in the
-chain gene locus.
Alternatively, should this population represent a late DN thymocyte
ready to progress into the CD4
CD8loCD3
stage, we
predict we would be able to detect D
-J
rearrangements.
|
We purified DNA from the thymuses harvested from the
Rag1
/
c-Myb
/
and the Rag1
/
mice, as well as
from both whole thymus and sorted CD4
CD8
CD3
thymocytes from
+/+ 129 mice and analyzed them for TCR
-chain gene
rearrangement using a PCR-based method (Anderson et al. 1992
). PCR
products representing initial D
-J
rearrangements can be readily detected in either whole thymocytes or
sorted CD4
CD8
CD3
cells from the +/+ 129 mouse
(open arrow; Fig. 4). We cannot detect similar rearrangements in the
Rag1
/
mouse, although the
germ-line D
-J
can be readily detected
(open and solid arrows, respectively; Fig. 4). These latter
observations are consistent with the inability of these mice to
rearrange their TCR and immunoglobulin genes due to the loss
of the functional Rag1 gene. Interestingly, we also cannot
detect D
-J
rearrangments in the thymuses
of the
Rag1
/
c-Myb
/
mice. However, in all chimeras we detect a PCR product that corresponds to the germ-line D
-J
band, demonstrating
that the
-chain loci in the DN thymocytes in these mice are still
in the germ-line configuration (solid arrow, Fig. 4). These data thus
suggest that the TCR
-chain loci in the expanded population of
CD44loCD25
DN thymocytes in the
Rag1
/
c-Myb
/
mice are germ line, indicating further that this population represents the earliest DN thymocyte stage.
| |
Discussion |
|---|
|
|
|---|
c-Myb is important at multiple stages in hematopoiesis
Previous studies have demonstrated that c-Myb is necessary for the
transition from fetal-type to adult-type erythropoeisis (Mucenski et
al. 1991
). In this study we present evidence that ES cells deficient
for c-Myb cannot generate B cell or macrophage/monocyte precursors in the bone marrow. There are several possible explanations for these observations: (1) The
c-Myb
/
HSC is present in
normal numbers but is inhibited from further development into the B
cell and macrophage/monocyte lineages but not the T cell
lineage; and (2) it is possible that
c-Myb
/
HSCs can develop but
are at a selective disadvantage for developmental niches in the bone
marrow. For example, should the
c-Myb
/
HSC be unable to
replicate efficiently, competition for the limited space in the bone
marrow with Rag1
/
HSCs may
inhibit the ability of the
c-Myb
/
HSC to populate this
compartment. Antisense experiments led to the proposal that c-Myb is
important in the proliferation and differentiation of hematopoietic
precursors (Clarke et al. 1988
; Gewirtz and Calabretta 1988
; McMahon et
al. 1988
; Todokoro et al. 1988
; McClinton et al. 1990
), which is
consistent with the latter hypothesis but not the former. However, as
we can detect further development of the
c-Myb
/
HSCs into thymic stem
cells in many of the
Rag1
/
c-Myb
/
mice, it is clear that HSC development and maturation can occur to some
extent in the absence of c-Myb. We thus believe that the absence of
c-Myb leads at best to only a partial developmental block at early
stages of HSC development. Thus, in contrast to the essential role that
c-Myb has in early thymopoiesis and fetal erythropoiesis, c-Myb is not
absolutely required for HSC maintenance and development.
Definitive roles for c-Myb in T cell development
Our data demonstrate that although
Rag1
/
c-Myb
/
mice
are capable of generating early hematopoietic precursors that seed the thymus, further development of these cells is blocked at the
CD44loCD25
DN developmental stage, which is characterized
by the beginning of definitive T cell differentiation. Thus, our data
demonstrate an important role for c-Myb in the control of early T cell
development. Although these cells eventually develop into T cells in
vivo, cell transfer experiments have demonstrated that this population is capable of differentiating into T, B, NK, and dendritic cells, whereas subsequent DN thymocyte stages are completely committed to the
T cell lineage (Guidos et al. 1989a
,b
; Wu et al. 1991
; Shortman and Wu
1996
). It is interesting to speculate that c-Myb plays a role in the
developmental decision of an ES cell precursor to commit to the T cell
lineage. In this model, the targeted disruption of c-Myb would prevent
the development of the committed DN thymocyte, leading to the observed
buildup of the early uncommitted precursor. Although several
transcription factors have been demonstrated previously to be important
in thymopoiesis, all are believed to be important either late in T cell
development or in the multipotent ES cell and not at this stage of T
cell commitment (Fig. 5). Using the
Rag
/
blastocyst chimera
approach, Ting et al. (1996)
determined that Rag2
/
GATA-3
/
mice are deficient in T cell development, indicating that GATA-3 is
important for the specification of the T cell lineage. However, using
the same Ly9 allele marker system that we have utilized above, these
workers could not detect Ly9.1+ DN thymocytes in the thymuses of
these mice, indicating that the
GATA-3
/
HSC could not seed the
thymus at any level. These observations suggest that the block in the
Rag2
/
GATA-3
/
mice is earlier
than that seen in the
Rag1
/
c-Myb
/
mice. However, because the expanded CD44loCD25
DN
population in the Rag1
/
c-Myb
/
mice cannot mature
further, it is difficult to define precisely their developmental
potential; thus we cannot formally demonstrate that this population
consists of the early uncommitted thymic ES cell. Nonetheless, this
population phenotypically resembles this thymocyte precursor; thus, our
data suggest that c-Myb may be playing a role in the committment of the
ES cell to the T cell lineage.
|
It is unlikely that the sole role of c-Myb in T cell development is
mediating early T cell progenitor development. As discussed above,
c-Myb is an important transcription factor in the control of expression
and function of a wide variety of different genes, including the
CD4, ADA, TCR
and
chain, c-kit, and c-Myc
genes (Siu et al. 1992
; Cogswell et al. 1993
; Hernandez-Munain and
Krangel 1994
; Hernandez-Munain et al. 1996
; Ess et al. 1995
; Hsiang et al. 1995
; Ratajczak et al. 1998
; M. Adlam, R.D. Allen, and G. Siu, in
prep.); many of these genes are important at later stages of T cell
development. For example, the CD4 and
TCR
- and
-chain genes
encode proteins whose expression are required for the T cell
receptor-mediated selection process (Fowlkes and Pardoll 1989
). In
addition, overexpression of dominant-negative forms of Myb lead to
perturbations in thymic development, implying a role for Myb proteins
in late stages of thymopoiesis (Badiani et al. 1994
; Taylor et al.
1996
). Nonetheless, the extent of the role of c-Myb in thymic selection
remains to be determined (Fig. 5). Use of conditionally targeted c-Myb
mice will allow insight into the role of c-Myb as a potential mediator
of proliferation or survival signals in the selecting and postselection thymocyte.
| |
Materials and methods |
|---|
|
|
|---|
RAG1
/
blastocyst
complementation and implantation
Homozygous and heterozygous null c-Myb ES cells were kindly
provided by M. Mucenski (Mucenski et al. 1991
).
Rag1
/
blastocysts were
harvested from impregnated females at 3.5 dpc, microinjected with
15-18 c-Myb
/
or
c-Myb+/
ES cells, and implanted
into the uteri of pseudopregnant females as described previously (Chen
et al. 1993
). Chimerism in the pups was determined by coat color, and
PCR and genomic blot analyses of tail DNA; a total of 11 chimeras were
obtained. Chimerism in each tissue was determined by genomic PCR
analyses, genomic blots, and flow cytometry. All mice were housed in
the pathogen-free Cancer Center Animal Facility at Columbia University
and sacrificed at 4-6 weeks of age for analysis.
Genomic DNA analyses
Genomic DNA was prepared from tissues and sorted cells by
incubating overnight at 55°C in digestion buffer (50 mM
Tris at pH 8.0, 100 mM NaCl, 100 mM EDTA, 1% SDS,
200 µg/µl proteinase K), extracting with
phenol/chloroform/isoamyl alchohol, and
resuspending the precipitated DNA in TE (10 mM Tris, 1 mM EDTA at pH 7.5). For PCR of the TCR
-chain gene locus,
primers 5' of the D
2 region (Anderson et al. 1992
)
and 3' of the J
2 cluster (Levin et al. 1993
) were
used to amplify DNA isolated from either whole or CD4
CD8
CD3
sorted thymocytes of chimeric and control mice. The amplification cycle
(94°C for 60 sec, 62°C for 120 sec, 72°C for 120 sec) was repeated for 40 cycles, and products were size fractionated on a 1%
agarose gel and visualized by ethidium bromide staining.
Flow cytometry
Cells were harvested and stored as described previously (Kim and
Siu 1998
). The following mAb reagents were obtained from PharMingen
(San Diego, CA):
-CD8 (53-7.8),
-Ly9.1 (30C7),
-CD4 (GK1.5),
-CD25 (7D4),
-IgM (331);
-CD4 (GK1.5),
-CD3 (145-2C11),
-CD44 (IM7),
-CD43 (S7);
-Ly9.1
(30C7),
-CD25 (7D4),
-Gr-1 (RB6-8C5);
-Thy1.2 (53-2.1),
-B220 (RA3-6B2),
-Mac-1 (M1-70),
-CD4 (RM4-5),
-Ter-119,
-Gr-1 (RB6-8C5),
-CD8 (53-6.1), and
-CD3
(145-2C11). T cell populations in the thymus and spleen were identified
with anti-CD3, anti-CD4, and anti-CD8. For DN T cells, thymocytes were
stained with antibodies to CD8, CD3, CD44, CD25, B220, Mac-1, Gr-1,
Ter-119, and Ly9.1. Cells expressing any one of the
CD8/CD3/B220/Mac-1/Gr-1/Ter-119
markers were excluded and the remainder analyzed on the basis of their
expression of CD25 and CD44. Mature B cells were identified in the
spleen using anti-B220 and anti-IgM. B cell precursors were identified
in bone marrow using anti-B220 and anti-CD43. Splenic macrophages and granulocytes were identified using Mac-1 and Gr-1 after excluding CD3-expressing cells from the analysis. Sorting for
CD4
CD8
CD3
thymocytes was performed as described previously
(Lam and Stall 1994
).
| |
Acknowledgments |
|---|
We thank Monica Mendelson and Dan Ng for technical assistance, and Drs. Kathryn Calame, Chris Schindler, and Alexander Dent for critical review of the manuscript. This work was funded by grants from the National Institutes of Health (NIH) (AI34925) and the Irma T. Hirschl-Monique Weill Caulier Trust to G.S. and grants from the NIH (GM55985) and the Fogarty Foundation (TW02297) to T.P.B. R.D.A. was supported by NIH training grant T32AI07525.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked `advertisement' in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
[Key Words: c-Myb; T cell development; lineage commitment]
Received February 8, 1999; revised version accepted March 24, 1999.
2 Corresponding author.
E-MAIL siu{at}cusiu3.cpmc.columbia.edu; FAX (212) 305-8013.
| |
References |
|---|
|
|
|---|
-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck.
EMBO J.
11:
4877-4886[Medline].
T and B cells get together.
Cell
96:
13-23[CrossRef][Medline].
CD4
CD8
triple-negative adult mouse thymocytes defined by CD44 and CD25 expression.
J. Immunol.
150:
4244-4252[Abstract].
8
thymocytes. Peripheral progeny include mature CD4
8
T cells bearing
T cell receptor.
J. Immunol.
142:
3773-3780[Abstract].
enhancer by functional cooperation between c-Myb and core-binding factors.
Mol. Cell. Biol.
14:
473-483
gene rearrangement by c-Myb.
J. Exp. Med.
183:
289-293
gene enhancer.
J. Immunol..
154:
5195-5204[Abstract].This article has been cited by other articles:
![]() |
M. R. Lidonnici, F. Corradini, T. Waldron, T. P. Bender, and B. Calabretta Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis Blood, May 1, 2008; 111(9): 4771 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O'Neil, J. Tchinda, A. Gutierrez, L. Moreau, R. S. Maser, K.-K. Wong, W. Li, K. McKenna, X. S. Liu, B. Feng, et al. Alu elements mediate MYB gene tandem duplication in human T-ALL J. Exp. Med., December 24, 2007; 204(13): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Clappier, W. Cuccuini, A. Kalota, A. Crinquette, J.-M. Cayuela, W. A. Dik, A. W. Langerak, B. Montpellier, B. Nadel, P. Walrafen, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children Blood, August 15, 2007; 110(4): 1251 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saether, T. Berge, M. Ledsaak, V. Matre, A. H. Alm-Kristiansen, O. Dahle, F. Aubry, and O. S. Gabrielsen The Chromatin Remodeling Factor Mi-2{alpha} Acts as a Novel Co-activator for Human c-Myb J. Biol. Chem., May 11, 2007; 282(19): 13994 - 14005. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mao, E. G. Tili, M. Dose, M. C. Haks, S. E. Bear, I. Maroulakou, K. Horie, G. A. Gaitanaris, V. Fidanza, T. Ludwig, et al. Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition J. Immunol., May 1, 2007; 178(9): 5443 - 5453. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakata, S. Shetzline, C. Sakashita, A. Kalota, R. Rallapalli, S. I. Rudnick, Y. Zhang, S. G. Emerson, and A. M. Gewirtz c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression Mol. Cell. Biol., March 15, 2007; 27(6): 2048 - 2058. [Abstract] [Full Text] [PDF] |
||||
|
|